Synopsys

At a glance

Synopsys reported 2025 revenue of $7.05B, up 15.1% from $6.13B in 2024. Over 4 years since 2021 ($4.2B), that is growth of about 13.8% a year. Operating margin was 13%, down from 17.5% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 5 insiders reported 0 open-market purchases and 11 sales ($61.5M). 9 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $21.4M by EXECUTIVE CHAIR Geus Aart De on Sep 2, 2026.

Synopsys filed 14 current reports (Form 8-K) in the last 12 months, most often for officer or director change (5), results of operations (4), other events (2) and exit or restructuring costs (2). The latest officer or director change was reported on Aug 12, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.

6 of the 20 investors tracked here held Synopsys at the last quarter end, worth $524.6M combined. It is the largest weight for Elliott Investment Management (0.7% of its portfolio), followed by Coatue Management (0.3%). New this quarter: Elliott Investment Management. Added: ARK Investment Management and National Pension Service (Korea). Reduced: Coatue Management, Bridgewater Associates and Renaissance Technologies.

Annual results

Fiscal year ends Oct 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.